Journey Medical Corporation (DERM) NASDAQ

7.71

-0.21(-2.65%)

Updated at December 29 04:00PM

Currency In USD

Valuation

Market Cap79.89M
Enterprise Value85.29M
P/E Ratio-20.55
PEG Ratio-8.22
Price/Sales Ratio3.15
Price/Book Ratio9.33
Enterprise/Revenue3.24
Enterprise/EBITDA-153.79

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.15
Operating Margin-0.12

Management Effectiveness

Return On Assets-0.11
Return On Equity-0.49

Income Statement

Revenue56.13M
Revenue/Share2.42
Gross Profit35.26M
EBITDA-8.4M
Net Income-14.67M
Diluted EPS-0.72

Balance Sheet

Total Cash24.95M
Total Cash/Share0.87
Total Debt25.3M
Total Debt/Equity1.31
Current Ratio1.27
Book Value Per Share0.83

Price History

52-Week Change94.21
52-Week High9.4
52-Week Low3.54
Moving Average 50 Days7.96
Moving Average 200 Days7.23

Statistics

Average Volume178,701
Shares Outstanding23.05M
% Held by Institutions36.75

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A